Pets Anti-infective Drugs Market - Global Forecast 2026-2032

The pets anti-infective drugs market is evolving rapidly, shaped by rising standards of veterinary care, enhanced clinical protocols, and growing owner awareness of stewardship. Senior decision-makers in veterinary pharmaceuticals, supply, procurement, and clinic management require a clear understanding of changing demand drivers, regulatory rigor, and commercial risks.

Market Snapshot: Pets Anti-Infective Drugs Market

The pets anti-infective drugs market grew from USD 1.04 billion in 2025 to USD 1.10 billion in 2026. It is projected to maintain a CAGR of 6.74%, reaching USD 1.65 billion by 2032. This growth reflects the sector's response to more sophisticated veterinary care, antimicrobial stewardship, and higher pet owner expectations.

Scope & Segmentation

Animal Type: Focus on dogs, cats, and select companion and niche pets, each presenting unique prescribing, adherence, and treatment needs.
Therapy Class: Includes antibiotics, antifungals, antivirals, and antiparasitics. Each class has distinct stewardship implications and monitoring requirements.
Infection Type: Covers dermatologic, otitic, urinary tract, respiratory, gastrointestinal, post-surgical, and wound-related infections with differing protocols.
Route of Administration: Emphasis on oral, injectable, and topical formats, reflecting clinical practicality and owner compliance needs.
Distribution Channel: Encompasses veterinary hospitals/clinics, retail pharmacies, and e-commerce, aligning with evolving procurement and owner purchase behaviors.
End-User Setting: Served segments include general practices, specialty/referral hospitals, and shelter/rescue organizations, each with unique care and budget priorities.
Geographies: Americas, Europe Middle East & Africa, and Asia-Pacific regions, each highlighting diverse regulations, veterinary infrastructure, and access needs.

Key Takeaways

Evidence-based therapy is steadily replacing empiric, convenience-driven prescribing due to increased diagnostic adoption and resistance concerns.
Antimicrobial stewardship is operationalized in clinics via practice guidelines, dosing education, and restricted formularies, influencing both product adoption and owner adherence.
Consolidation among veterinary service providers drives protocol standardization, supply arrangement optimization, and demand for reliable distribution and clinical support skills.
Product innovation prioritizes improved palatability, dosing formats, combination therapies, and digital tools that facilitate treatment adherence and monitoring.
Supply chain reliability secures competitive advantage, particularly where therapy continuity affects clinical outcomes and client loyalty.
Regional variations require tailored commercial and portfolio strategies to accommodate differences in stewardship, distribution infrastructure, and pet ownership trends.

Tariff Impact on Supply and Pricing Discipline

Recent tariff changes in the United States are introducing cost pressures across sourcing, manufacturing, and distribution for the pets anti-infective drugs market. Manufacturers are re-evaluating supply chain designs, weighing margin protection, pricing strategies, and dual-sourcing or localizing production. These dynamics are particularly acute for commodity and generic drug suppliers whose buyers remain highly price-sensitive. Distributors and group clinics are negotiating harder for predictable supply and risk-sharing contract structures, promoting resilience through strategic planning and scenario modeling.

Methodology & Data Sources

Our analysis combines structured primary research—including interviews with veterinarians, clinic procurement leaders, distributors, and industry executives—with comprehensive secondary review of regulations, clinical literature, and public disclosures. Triangulation of diverse insights ensures robust, actionable conclusions directly tied to prevailing veterinary prescribing and supply realities.

Why This Report Matters

Supports strategic planning for supply resilience, commercialization, and protocol-driven engagement in a changing competitive landscape.
Delivers precise segmentation and regional intelligence for market entry, portfolio positioning, or channel optimization across the pets anti-infective drugs sector.
Equips decision-makers to anticipate regulatory, stewardship, and supply disruptions—fostering more agile and sustainable operations.

Conclusion

The next era of pets anti-infective drugs will be defined by stewardship-driven innovation, supply resilience, and integration into standardized clinical protocols. Companies aligning products and strategies with these needs are well-positioned to improve care outcomes and reinforce market leadership.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Pets Anti-infective Drugs Market, by Drug Class

8.1. Antibiotics
8.1.1. Aminoglycosides
8.1.2. Beta-Lactams
8.1.3. Macrolides
8.1.4. Tetracyclines
8.2. Antifungals
8.2.1. Azoles
8.2.2. Polyenes
8.3. Antiparasitics
8.3.1. Anticoccidials
8.3.2. Endectocides
8.4. Antivirals

9. Pets Anti-infective Drugs Market, by Animal Type

9.1. Cats
9.2. Dogs
9.3. Horses
9.4. Small Mammals
9.4.1. Rabbits
9.4.2. Rodents

10. Pets Anti-infective Drugs Market, by Route Of Administration

10.1. Oral
10.2. Parenteral
10.2.1. Intramuscular
10.2.2. Intravenous
10.2.3. Subcutaneous
10.3. Topical

11. Pets Anti-infective Drugs Market, by Distribution Channel

11.1. Online Retailers
11.2. Retail Pharmacies
11.3. Veterinary Hospitals
11.4. Veterinary Pharmacies

12. Pets Anti-infective Drugs Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Pets Anti-infective Drugs Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Pets Anti-infective Drugs Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Pets Anti-infective Drugs Market
16. China Pets Anti-infective Drugs Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Bayer Animal Health
17.6. Bimeda Animal Health
17.7. Boehringer Ingelheim Animal Health
17.8. Cargill Inc.
17.9. Ceva Santé Animale
17.10. China Animal Healthcare Ltd.
17.11. China Animal Husbandry Industry Corporation
17.12. Dechra Pharmaceuticals PLC
17.13. Elanco Animal Health Incorporated
17.14. Evonik Industries AG
17.15. Guangdong Wens Dahuanong Biotechnology Co. Ltd.
17.16. Hester Biosciences Ltd.
17.17. Huvepharma
17.18. IDEXX Laboratories, Inc.
17.19. Intas Pharmaceuticals
17.20. Kyoritsu Seiyaku Corporation
17.21. Merck Animal Health
17.22. Nippon Zenyaku Kogyo Co., Ltd.
17.23. Norbrook Laboratories
17.24. Nutreco N.V.
17.25. Phibro Animal Health Corporation
17.26. Prodivet Pharmaceuticals SA/NV
17.27. Vetoquinol S.A.
17.28. Virbac S.A.
17.29. Zoetis Inc.

List of Figures

FIGURE 1. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY BETA-LACTAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY BETA-LACTAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY BETA-LACTAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AZOLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AZOLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AZOLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY POLYENES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY POLYENES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY POLYENES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTICOCCIDIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTICOCCIDIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTICOCCIDIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY HORSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY HORSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RABBITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RABBITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RABBITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RODENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RODENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RODENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 145. EUROPE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 158. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 159. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 160. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 161. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 162. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 163. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 164. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 165. AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 179. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 180. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 181. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 182. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 183. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 184. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 186. ASEAN PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 187. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 189. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 190. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 191. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 192. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 193. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 194. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 195. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 196. GCC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 209. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 210. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 211. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 212. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 213. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 214. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 215. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 216. BRICS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 219. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 220. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 221. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 222. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 223. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 224. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 226. G7 PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 229. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 230. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 231. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 232. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 233. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 234. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 235. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 236. NATO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 249. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 250. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 251. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 252. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 253. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 254. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 255. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 256. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 257. CHINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Pets Anti-infective Drugs market report include:

Bayer Animal Health
Bimeda Animal Health
Boehringer Ingelheim Animal Health
Cargill Inc.
Ceva Santé Animale
China Animal Healthcare Ltd.
China Animal Husbandry Industry Corporation
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Evonik Industries AG
Guangdong Wens Dahuanong Biotechnology Co. Ltd.
Hester Biosciences Ltd.
Huvepharma
IDEXX Laboratories, Inc.
Intas Pharmaceuticals
Kyoritsu Seiyaku Corporation
Merck Animal Health
Nippon Zenyaku Kogyo Co., Ltd.
Norbrook Laboratories
Nutreco N.V.
Phibro Animal Health Corporation
Prodivet Pharmaceuticals SA/NV
Vetoquinol S.A.
Virbac S.A.
Zoetis Inc.

Table Information

Report Attribute	Details
No. of Pages	190
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.1 Billion
Forecasted Market Value ( USD ) by 2032	$ 1.65 Billion
Compound Annual Growth Rate	6.7%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3447EUR$3,939USD£2,988GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3719EUR$4,249USD£3,223GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5040EUR$5,759USD£4,368GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6099EUR$6,969USD£5,286GBP

Market Snapshot: Pets Anti-Infective Drugs Market

Scope & Segmentation

Key Takeaways

Tariff Impact on Supply and Pricing Discipline

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Anti-Infective Agents for Pets Market - Global Forecast 2025-2030

Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis

Anti-infectives Market - Global Forecast 2026-2032

Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033

Anti-Infectives - Global Strategic Business Report